• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于配体的非二甲苯基二芳基嘧啶的设计,改善了代谢稳定性、安全性和口服药代动力学特征。

Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.

机构信息

Engineering Center of Catalysis and Synthesis for Chiral Molecules, Department of Chemistry , Fudan University , Shanghai 200433 , People's Republic of China.

Shanghai Engineering Center of Industrial Asymmetric Catalysis for Chiral Drugs , Shanghai 200433 , People's Republic of China.

出版信息

J Med Chem. 2019 Dec 26;62(24):11430-11436. doi: 10.1021/acs.jmedchem.9b01446. Epub 2019 Dec 16.

DOI:10.1021/acs.jmedchem.9b01446
PMID:31714780
Abstract

A series of nondimethylphenyl-diarylpyrimidines with much lower cytotoxicities than their dimethyl analogues were developed. Compound with a difluorobiphenyl moiety showed the highest antiviral activity against WT, mutant strains, and RT. The hydrochloride form of exhibited an improved water solubility of 5.6 μg/mL compared with ETR (≪1 μg/mL), better stability in human and rat liver microsomes, and a great oral bioavailability of 44%, making it promising as a drug candidate. In addition, no apparent toxicity was observed in the acute toxicity assay (2 g/kg) and HE staining.

摘要

我们开发了一系列比其二甲苯基类似物毒性低得多的非二甲基苯基二苯并嘧啶。带有二氟联苯部分的化合物 对 WT、突变株和 RT 显示出最高的抗病毒活性。盐酸盐形式的 与 ETR(≪1 μg/mL)相比,具有 5.6 μg/mL 的改善的水溶性,在人肝和大鼠肝微粒体中更稳定,口服生物利用度高达 44%,有望成为候选药物。此外,在急性毒性试验(2 g/kg)和 HE 染色中未观察到明显的毒性。

相似文献

1
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.基于配体的非二甲苯基二芳基嘧啶的设计,改善了代谢稳定性、安全性和口服药代动力学特征。
J Med Chem. 2019 Dec 26;62(24):11430-11436. doi: 10.1021/acs.jmedchem.9b01446. Epub 2019 Dec 16.
2
Design and synthesis of hybrids of diarylpyrimidines and diketo acids as HIV-1 inhibitors.作为HIV-1抑制剂的二芳基嘧啶与二酮酸杂合物的设计与合成
Bioorg Med Chem Lett. 2017 Apr 15;27(8):1640-1643. doi: 10.1016/j.bmcl.2017.03.009. Epub 2017 Mar 7.
3
Fragment Addition-Based Design of Heteroaromatic-Biphenyl-DAPYs as Potent and Orally Available Non-nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Enhanced Safety.基于片段添加的杂芳基-联苯-DAPY 的设计作为有效且可口服的非核苷类逆转录酶抑制剂,具有显著增强的安全性。
J Med Chem. 2024 Oct 10;67(19):17568-17584. doi: 10.1021/acs.jmedchem.4c01571. Epub 2024 Oct 1.
4
Novel diaryltriazines with a picolinonitrile moiety as potent HIV-1 RT inhibitors: a patent evaluation of WO2016059647(A2).具有吡啶甲腈部分的新型二芳基三嗪作为高效HIV-1逆转录酶抑制剂:WO2016059647(A2)专利评估
Expert Opin Ther Pat. 2017 Jan;27(1):9-15. doi: 10.1080/13543776.2017.1262349. Epub 2016 Nov 25.
5
Novel nevirapine-like inhibitors with improved activity against NNRTI-resistant HIV: 8-heteroarylthiomethyldipyridodiazepinone derivatives.对耐非核苷类逆转录酶抑制剂(NNRTI)的HIV具有更高活性的新型奈韦拉平样抑制剂:8-杂芳基硫代甲基二吡啶并二氮杂䓬酮衍生物
Bioorg Med Chem Lett. 2004 Feb 9;14(3):739-42. doi: 10.1016/j.bmcl.2003.11.049.
6
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.CHX-DAPYs作为HIV-1非核苷类逆转录酶抑制剂的合成及生物学评价
Bioorg Med Chem. 2014 Jun 15;22(12):3220-6. doi: 10.1016/j.bmc.2014.03.020. Epub 2014 Mar 27.
7
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.二芳基嘧啶类及其相关类似物作为 HIV-1 非核苷逆转录酶抑制剂的研究进展。
Eur J Med Chem. 2018 Oct 5;158:371-392. doi: 10.1016/j.ejmech.2018.09.013. Epub 2018 Sep 6.
8
Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants.基于结构的噻吩并[3,2-d]嘧啶衍生物优化:作为强效HIV-1非核苷类逆转录酶抑制剂,对耐药相关变体的活性增强
J Med Chem. 2017 May 25;60(10):4424-4443. doi: 10.1021/acs.jmedchem.7b00332. Epub 2017 May 15.
9
Synthesis and structure-activity relationships of the (alkylamino)piperidine-containing BHAP class of non-nucleoside reverse transcriptase inhibitors: effect of 3-alkylpyridine ring substitution.
J Med Chem. 1999 Oct 7;42(20):4140-9. doi: 10.1021/jm990051a.
10
Structure-based evaluation of non-nucleoside inhibitors with improved potency and solubility that target HIV reverse transcriptase variants.针对HIV逆转录酶变体的具有更高效力和溶解性的非核苷抑制剂的基于结构的评估。
J Med Chem. 2015 Mar 26;58(6):2737-45. doi: 10.1021/jm501908a. Epub 2015 Mar 5.

引用本文的文献

1
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors.基于生物电子等排体原理设计具有口服活性、安全性高且广谱的联苯 - DAPY衍生物作为高效HIV-1非核苷类逆转录酶抑制剂
Acta Pharm Sin B. 2025 Aug;15(8):4115-4136. doi: 10.1016/j.apsb.2025.06.016. Epub 2025 Jun 24.
2
Natural compounds as lactate dehydrogenase inhibitors: potential therapeutics for lactate dehydrogenase inhibitors-related diseases.天然化合物作为乳酸脱氢酶抑制剂:与乳酸脱氢酶抑制剂相关疾病的潜在疗法。
Front Pharmacol. 2023 Oct 17;14:1275000. doi: 10.3389/fphar.2023.1275000. eCollection 2023.
3
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).
非核苷类逆转录酶抑制剂(NNRTIs)的设计和开发策略。
Viruses. 2023 Sep 25;15(10):1992. doi: 10.3390/v15101992.
4
Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability.逆转录酶的皮摩尔级抑制剂,具有显著提高的代谢稳定性。
Acta Pharm Sin B. 2023 Jul;13(7):3054-3066. doi: 10.1016/j.apsb.2023.03.022. Epub 2023 Mar 29.
5
Development of fluorine-substituted NH-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability.含氟取代的NH-联苯-二芳基嘧啶作为高效非核苷类逆转录酶抑制剂的研发:提高安全性和代谢稳定性
Acta Pharm Sin B. 2023 Mar;13(3):1192-1203. doi: 10.1016/j.apsb.2022.08.017. Epub 2022 Aug 27.
6
Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs.从 CH(CN)-DABO 到 CH(CN)-DAPY:HIV-1 非核苷类逆转录酶抑制剂发现中的支架跃迁。
Molecules. 2020 Mar 30;25(7):1581. doi: 10.3390/molecules25071581.
7
Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization Strategy.通过分子杂交策略设计具有氰基甲基连接基的联苯取代二芳基嘧啶作为HIV-1非核苷类逆转录酶抑制剂
Molecules. 2020 Feb 26;25(5):1050. doi: 10.3390/molecules25051050.
8
Discovery, synthesis, and optimization of an N-alkoxy indolylacetamide against HIV-1 carrying NNRTI-resistant mutations from the Isatis indigotica root.从板蓝根中发现、合成和优化一种针对带有 NNRTI 耐药突变的 HIV-1 的 N-烷氧基吲哚基乙酰胺。
Eur J Med Chem. 2020 Mar 1;189:112071. doi: 10.1016/j.ejmech.2020.112071. Epub 2020 Jan 22.